Introduction
The SRE is a pivotal regulatory sequence in the promoter of several immediate early genes (Treisman, 1995) . This element mediates the response to a wide variety of signals, including growth factors, cytokines or stress (Treisman, 1990) . Several signal transduction pathways converge on the SRE and lead to distinct transcription factors. A poorly de®ned pathway, which is triggered by serpentine receptors and involves members of the Rho/Rac1 family, leads to p67SRF or SRF (Hill et al., 1995) . SRF, a member of the MADS box family of proteins, binds as a homodimer to a CArG box in the SRE (Norman et al., 1988) . SRF also mediates transcriptional responses to the calcium/ calmodulin-dependent kinase (Miranti et al., 1995) . The main transduction pathway leading to the SRE, the Ras/MAP kinase pathway (Leevers and Marshall, 1992; Marshall, 1993) , is triggered by several mitogens, such as EGF or serum and other cytokines such as NGF (Gotoh et al., 1990; Cowley et al., 1994) . The direct target of this pathway p62TCF (Shaw et al., 1989 ) is a member of the Ets protein family, which recognises an Ets box immediately adjacent to the CArG box and which is phosphorylated by MAPkinases (Janknecht et al., , 1995 Marais et al., 1993; Zinck et al., 1993; Gille et al., 1995) .
Proteins from the Ets family share a highly conserved 85 amino acid domain, the Ets domain, which recognises a speci®c DNA sequence present in the transcriptional regulatory regions of a variety of cellular and viral genes (Wasylyk et al., 1993) . Only a subset of the Ets proteins bind to the SRE Ets box . These proteins bind to some Ets sequences autonomously; but on the SRE, they form ternary, and in some instances quaternary (Gille et al., 1996) complexes in which the interaction between the Ets-protein and the DNA is stabilised by a protein ± protein interaction with SRF (Shore and Sharrocks, 1994) . Elk-1 (Hipskind et al., 1991) and the SAP proteins (SAP-1 (Dalton and and SAP2/Net/ERP (Giovanne et al., 1994; Lopez et al., 1994; Price et al., 1995) belong to the TCF subset of Ets-proteins. In addition, some oncogenic fusion proteins from the Ets family are also able to form ternary complexes, although to a lesser extent (Magnaghi-Jaulin et al., 1996) . The Ets domain of TCF proteins, when isolated, is able to recognise autonomously the SRE Ets box in the absence of SRF (Shore and Sharrocks, 1995) . The B-box, the domain which is involved in the interaction with SRF (Dalton et al., 1992) , is thought to inhibit the autonomous binding of the TCFs on a subset of Ets-boxes, including that of c-fos. We here show that the full length SAP-1 protein in fact displays some anity for the c-fos SRE ets-box, as demonstrated in vitro, by EMSA, or in live cells, by co-transfection experiments. Deletion of the B-box did not increase the anity, indicating that the B-box does not act as an inhibitor for c-fos Ets-box recognition.
Results and discussion

Autonomous binding of Ets proteins to the SRE
The TCFs SAP-1a and Elk-1 bind autonomously to and transactivate some Ets sequences, such as the binding site for the Drosophila protein E74 . In addition, it is well established that the Ets-domains of SAP-1 and Elk-1, when isolated from the context of the whole protein, are able to recognise the SRE Ets box in the c-fos promoter, albeit with a lower anity (Shore and Sharrocks, 1995) . As seen in Figure 1b , the full length SAP-1a protein also displays some anity for the c-fos SRE, as well as for the homologous Ets box from the GpIIb promoter, at least (Figure 1b) , and Elk-1 could only be signi®cantly recruited to this element in the presence of SRF (Figure 1c ). The position of the SAP-1a complex corresponded to a low molecular weight complex, consistent with the autonomous binding of SAP-1 to the probe. Furthermore, anti-SAP-1a supershifted the complex whereas anti-SRF antibodies did not (data not shown), indicating that the complex was due to the autonomous binding of SAP-1a. The autonomous complex was also detected in the presence of SRF (Figure 1d , lane 3). Under these conditions, about half of the detected protein was in the ternary complex (CIII) and the other half was autonomously bound (CI). The speci®city of SAP-1a binding was con®rmed by competition experiments. The binding was not aected by mutations introduced into the CArG box ( Figure 1e , m2CArG-SRE), strongly suggesting that it did not require SRF. Note that in the m2CArG-SRE mutant, the binding site of SRF was eciently inactivated and no complex with SRF could be detected (Figure 1e , lane 7). On the other hand, binding was not inhibited by an excess of an oligonucleotide which does not include the Ets site ( Figure 1d , mEts-SRE), whereas it was inhibited by competitors which include the Ets element from the SRE (data not shown), or a consensus Ets-sequence from the GpIIb promoter (Figure 1d , GpIIb). Also, no binding could be detected on an oligonucleotide in which the Ets box had been inactivated (Figure 1e , mEts-SRE). Indeed, the formation of the complex also depended on the nucleotides¯anking the core CAGGA on the 3' side of the oligonucleotide used as a probe. A truncated version of this oligonucleotide, such as that used in some studies (Dalton and Treisman 1992), was not detectably recognised by SAP-1a in the absence of SRF (data not shown). Taken together, these data indicate that SAP-1 displays some anity for the SRE in the absence of SRF. In vitro translated products were tested by EMSA using the wtSRE (lanes 1 ± 5), the m2CArG-SRE (lanes 6 ± 10), or the mEts-SRE oligonucleotides as probes. Lanes 1, 6, 11, control reticulocyte lysate; lanes 2, 7, 12, SRF alone; lanes 3, 8, 13, Elk-1 alone; lanes 4, 9, 14, SAP-1a alone; lanes 5, 10, 15, SRF and SAP-1a
Activation of the SRE by SAP-1a
The autonomous binding of SAP-1 to the SRE is not modulated by the B-box
The autonomous binding of SAP-1 to low anity binding sites, such as the c-fos SRE (and not to high anity binding sites, Shore and Sharrocks 1995) has been thought to be inhibited by an intramolecular mechanism involving the B-box, the region of the molecule responsible for interaction with SRF . In order to test this hypothesis, we have constructed a mutant of SAP-1a, SAP-1a DB, in which the B box has been deleted ( Figure 2a ). This mutant did not form a ternary complex, as assessed by EMSA in the presence of SRF (data not shown). Equal amounts of SAP-1a and SAP-1a DB ( Figure 2b) were assayed in the absence of SRF. The anity of the DB mutant for the SRE was not higher than that of the wild type molecule (Figure 2c , compare lane 2 and lane 3). This result indicates that the B box does not modulate the binding of SAP-1 to low anity Ets-boxes such as that of c-fos. The autonomous binding of SAP-1 to the SRE is not modulated after phosphorylation by p44 MAP-kinase
In the course of the response to external stimuli, the activity of TCF proteins is modulated through phosphorylation by MAP-kinases. The eect of TCF phosphorylation by MAP-kinase varies from one TCF to the other. In particular, ELK-1 phosphorylation may increase the rate of ternary complex formation, at least in vitro (Gille et al., 1992 (Gille et al., , 1995 , although this observation is controversial . On the other hand, SAP-1 phosphorylation does not seem to modify the formation of a ternary complex with SRF (Hipskind et al., 1994) . Similarly, we show that quantitative phosphorylation of SAP-1a by p44 MAP-kinase (Figure 3a) did not aect the level of the autonomous binding to the SRE (Figure 3b , compare lanes 2 and 3). Note that the phosphorylation resulted in an accelerated migration in EMSA (Figure 3b ). Taken together, these data indicate that the binding of SAP-1a to the SRE, either as a ternary complex with SRF or alone, is not aected, at least in vitro, by the phosphorylation by MAP-kinases.
SAP-1a restores the response of a CArG-less SRE
Our data indicate that SAP-1a binds to the SRE autonomously with an anity sucient for detection by EMSA. In order to demonstrate that this autonomous binding was also detectable in live cells, we performed co-transfection experiments. Our approach was based on the use of SRE-luciferase reporter constructs in which the binding site for SRF was inactivated. The Ras/MAP kinase transduction pathway was triggered using NGF, a well-de®ned stimulus of this pathway, which activates the SRE (Figure 4a ) through the Ets box (Bonni et al., 1995 , and data not shown). CArG-less SREs (see Figure 1a , m1CArG-SRE and m2CArg-SRE) were essentially unable to respond to NGF (Figure 4b ). When SAP1a was co-expressed, a signi®cant response was observed (Figure 4b ), although the level of this response was lower than that obtained with the wild type SRE element. The response was consistently observed using various CArG-less SRE elements ( Figure 4b ). In contrast, SAP-1a did not transactivate a basal promoter (Figure 4b ). The CArG box in the m2CArG-SRE oligonucleotide is drastically mutated and was not recognised by SRF, at least in vitro (Figure 1e ). SAP-1a, however, physically interacts with SRF in the absence of DNA (Shore and Sharrocks, 1994) . It remained possible, thus, that SRF was recruited to the promoter by a direct physical interaction with SAP-1a. In order to test this hypothesis, we have used a mutant of SAP1a, SAP-1a DB, in which the B-domain has been deleted (See Figure 2a) . The SAP-1a DB mutant was able to restore the response of a CArG-less element, with levels of transactivation similar to those observed for the wild type protein (Figure 4c ). This result indicates that the response occurred in the absence of SRF recruitment, either by the promoter element or by the SAP-1a protein. In contrast, a mutant of SAP1a which has lost both the B and the C domains (SAP-1a DBC see Figure 2a ) was unable to transactivate the promoter (Figure 4c ), indicating that transactivation required the integrity of the C (transactivation) domain, which is also a target for MAP kinases.
Transactivation of the SRE by SAP-1a results from activation of the Ras/MAP kinase pathway
NGF is known to activate the Ras/MAP kinase pathway (Gotoh et al., 1990) and, in our experiments, MAP kinases were indeed activated (data not shown). Accordingly, the response of a wild-type SRE was drastically repressed by a Ras transdominant negative mutant (Figure 5a , Ras Asn17), indicating that the signal was transduced through a pathway which requires the Ras protein. The eect of the Ras/ MAP kinase pathway on SAP-1a might depend on the cell type and activation is not consistently observed (Hipskind et al., 1994) . We show that the Ras transdominant negative mutant inhibited the response through SAP-1a in PC12 cells (Figure 5b ), indicating that this response is indeed triggered through Ras, a major component of the Ras/MAP kinase pathway. Taken together, our data indicate that SAP-1 displays a signi®cant anity for the SRE ets-box and forms a complex in the absence of SRF. This complex can be detected in vitro, by EMSA, or in vivo, by cotransfection experiments. Under physiological condi- tions, endogenous levels of SAP-1a are not sucient to observe a response in the absence of co-transfected SAP-1a. It is possible, however, that in some cell types, or in some situations, normal or pathological, TCF proteins which display an intermediate anity for the SRE ets-box, such as SAP-1a, might aect the regulation of this pivotal element of the immediate early response.
Materials and methods
Cells and culture
PC12 cells were maintained in RPMI 1640 (GIBCO, Grand Island, NY) supplemented with L-glutamine, antibiotics, 10% heat inactivated horse serum (Biochrom KG, Berlin, Germany), and 5% heat inactivated foetal calf serum (Biochrom KG). Nerve growth factor (Boehringer Mannheim, Mannheim, Germany) was used at 50 ng/ml.
Oligonucleotides
The following oligonucleotides (double-stranded) were used in EMSA or inserted into reporter constructs. SRE: TCGAGCTTACACAGGATGTCCATATTAGGAC ATC-C; mEts-SRE: TCGAGCTTACACACCATGTCCATATT-AGGACATCC; m1CArG-SRE: TCGAGCTTACACAG-GATGTTCATATTAGGACATCC; m2CArG-SRE: TCG-AGC T T AC ACAGGA T G T CCGACCCAGGACA T CC; GpIIB: CTCAGA T T CC T CCACAGGAAGTCCTTTGG-TAC (Zhang et al., 1993) .
Plasmids
The enhancerless minimal fos promoter, Fos-40 luc was constructed by subcloning a BamHI ± HindIII fragment of fos-40 CAT (Trouche et al., 1993) containing the promoter into the BgIII ± HindIII site of pGL2 basic vector (Promega).
Reporter plasmids including various versions of the SRE were constructed by inserting synthetic oligonucleotides into the XhoI sites of Fos-40 luc. The m2CArG-SRE3-luc contains three tandem repeats of the corresponding oligonucleotides. SRE3 luc was constructed by subcloning a BamHI ± HindIII fragment of SRE3 fos-40 CAT containing three tandem repeats of SRE sequence: (5'-ACAGGATGTCCATATTAG-GACATCTGCGTCAGC-3'). All constructs were controlled by direct nucleotide sequencing using an USB sequencing kit (USB, Ohio, USA).
pcDNA3-SAP-1a was constructed by subcloning the SAP-1 coding sequences from pT7SAP-1 into pcDNA3 (Invitrogen). pT7SAP-1 and pT7Elk-1 (kind gifts of R Treisman) encode, respectively the entire coding sequence of SAP-1a (1 ± 431), and the Elk-1 codons from 2 to 428. pcDNA3-SAP1aDB was constructed by deleting the PmeI-Bsu36 fragment from pcDNA3-SAP-1a. It encodes amino acids 1 to 107 in frame with amino acids 181 to 431 from SAP-1a. pcDNA3-SAP-1aDBC was made after PmeI digestion by end-®lling and religation. CMV SRF was constructed by replacing the HIV promoter of HIVSRF (described in Magnaghi-Jaulin et al., 1996) by the CMV promoter from pcDNA3. The bgalactosidase expression vector (CMVbgal) under the control of the CMV promoter was purchased from Cayla (Toulouse, France). RasAsn17 and pZIPNeo plasmids are kind gifts of GM Cooper and F Dautry, respectively.
In vitro transcription and translation
Recombinant SRF, Elk-1, SAP-1a, SAP-1aDB, and SAP1aDBC proteins were translated in vitro using a TnT kit, as recommended by the manufacturer (Promega). Experiments were run in parallel, in the presence or absence of [ 35 S]methionine. Radioactive products were analysed by SDS ± PAGE using standard procedures, and non radioactive products were used in EMSA.
Electrophoretic mobility shift assays (EMSA)
The SRE, mETS-SRE, m1CArG-SRE, m2CArG-SRE and GpIIb oligonucleotides, described in Figure 1a , were puri®ed on denaturing acrylamide gels, annealed and endlabeled using T4 polynucelotide kinase (Biolabs) and g- ATP. In vitro translated proteins (2 ± 5 ml) were preincubated with 1 ± 2 mg salmon sperm DNA in 20 ml of EMSA buer (188 mM NaCl, 50 mM HEPES pH 7.9, 2.5 mM EDTA pH 8, 2.5 mM DTT, 12% glycerol). After 15 min on ice, 32 P-labeled oligonucleotide probes (2 ng, corresponding to about 9610 3 c.p.m.) were added and the incubation was allowed to continue for an additional 15 min at room temperature. Samples were electrophoresed at 48C on a 4% polyacrylamide gel in 0.256TBE buer. Gels were dried and analysed by conventional autoradiography.
Transfection and luciferase assay
Transfection experiments were performed as previously described (Trouche et al., 1991) with slight modi®cations. Brie¯y, the cells were washed and resuspended in 0.5% horse serum supplemented with RPMI 1640. Cells were distributed in ectroporation cuvettes together with 3 mg of reporter and 100 ng of CMVbgal as a control for transfection eciency. Cells were electroporated using a Bio-Rad gene pulser (Bio-Rad) with 960 mFarads and 200V settings. Cells were resuspended in RPMI 1640 supplemented with 0.5% horse serum, divided into aliquots, and incubated for 16 h followed by induction with or without NGF for 4 h.
Alternatively, cells were transfected using Polyethyleneimine (PEI) (Boussif et al., 1995) . Brie¯y, 25 mg of a PEI 50 kDa solution (Sigma) was diluted in 50 ml distilled water. Cells were seeded at 5610 4 cells per well in 24-well dishes. Cells were rinsed and supplemented with serum-free culture medium (1 ml/well). 1 ± 2 mg/well of plasmids and 100 ng/well of CMV bGal expression vector were diluted with 150 mM NaCl to a total volume of 50 ml in a tube. Separately, PEI solution was diluted with 150 mM NACl to a total volume of 50 ml in another tube. The ratio of the PEI/ DNA was kept constant (2.7 ml/mg). The PEI solution was added to the plasmid solution and mixed by vortexing. After about 10 min, the mixture was added to each well and made homogeneous with the cell culture medium by a slow hand rotation. The cell culture dish was then centrifuged for 5 min at 1500 r.p.m. After 2 h, 5 ml foetal calf serum was added to each well.
Luciferase and b-galactosidase were assayed using chemiluminescence and kits from Promega and Tropix, respectively, using a Lumat B9501 luminometer (Berthold).
In vitro phosphorylation by MAP kinase 14 ml of in vitro translated lysate was treated by 20 ng of puri®ed p44 MAP kinase (Upstate Biotechnology Incorporated New York, USA) with 1 mM ATP in 20 ml for 10 min at room temperature. The phosphorylation was veri®ed by SDS ± PAGE using a 35 S-labelled SAP-1a in vitro translated protein with or without MAP kinase treatment. The ratio of acrylamide to bis-acrylamide was adjusted to 100:1. In vitro translated SAP-1a, with or without treatment by p44 MAP kinase in the presence of ATP, was analysed by EMSA using a wild type SRE as probe.
